Transpact Enterprises Ltd (542765) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542765 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Transpact Enterprise Share Price

165 0.00 0.00%
as on 20-Nov'25 16:59

Transpact Enterprises Ltd (542765) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542765 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on Transpact Enterprise

Based on:

M-Cap below 100cr DeciZen not available

Transpact Enterprises stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
709.00
Market Cap:
6.4 Cr.
52-wk low:
130.6
52-wk high:
299.4

Is Transpact Enterprises Ltd an attractive stock to invest in?

1. Is Transpact Enterprises Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transpact Enterprises Ltd is a below average quality company.

2. Is Transpact Enterprises Ltd undervalued or overvalued?

The key valuation ratios of Transpact Enterprises Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Transpact Enterprises Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transpact Enterprises Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Transpact Enterprise:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transpact Enterprises Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -19.5%-27.6%-66.2%-53.6%-5.2%-21.9%-7.9%-14.5%1%-
Value Creation
Index
-2.4-3.0-5.7-4.8-1.4-2.6-1.6-2.0-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000.1000.20.400.10
Sales YoY Gr.-NANA-100%NA400%153.3%-100%NA-
Adj EPS -1.6-3.2-10.6-11.2-1.7-5.7-1.7-2.40.20.2
YoY Gr.-NANANANANANANANA-
BVPS (₹) 5.82.60.122.921.215.513.811.411.711.7
Adj Net
Profit
-0.1-0.1-0.3-0.4-0.1-0.2-0.1-0.100
Cash Flow from Ops. -0.1-0.10.1-1.10-0.900.4-0.4-
Debt/CF from Ops. -1.4-0.92.8-0.226.2-0.332.40.1-0.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-18.9%NA
Adj EPS NANANANA
BVPSNA-12.6%-9%2.1%
Share Price - 4.9% 7.5% -29.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-27.6-37.6-103.9-76.3-7.5-31.1-11.6-18.622
Op. Profit
Mgn %
00-202.90-195.7-138.5-7.8051.2NAN
Net Profit
Mgn %
00-229.50-256.7-147.3-17.2010.911.2
Debt to
Equity
0.40.30.70.30.40.50.50.10.2-
Working Cap
Days
00386014,8862,30779901,4450
Cash Conv.
Cycle
0016602,10546-7401380

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 2.00%

Sales growth has been subdued in last 3 years -18.90%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Transpact Enterprises Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 -
TTM Sales (₹ Cr.) 0.1 -
BVPS (₹.) 11.7 -
Reserves (₹ Cr.) - -
P/BV 14.13 -
PE 709.00 -
From the Market
52 Week Low / High (₹) 130.60 / 299.40
All Time Low / High (₹) 86.00 / 483.80
Market Cap (₹ Cr.) 6.4
Equity (₹ Cr.) 0.4
Face Value (₹) 10
Industry PE 53.3

Management X-Ray of Transpact Enterprise:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Transpact Enterprise - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Transpact Enterprise

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales000.1300.030.150.3800.08
Operating Expenses 0.050.090.390.410.070.360.410.060.04
Manufacturing Costs000.010000.0100
Material Costs000.09000.280.1900
Employee Cost 0.010.040.010.020.030.040.110.020.02
Other Costs 0.030.050.270.390.050.050.100.040.02
Operating Profit -0.05-0.09-0.26-0.41-0.05-0.21-0.03-0.060.04
Operating Profit Margin (%) ---202.0%--195.0%-138.0%-7.8%-51.2%
Other Income 0000.020.030.03000
Interest 000000000
Depreciation 000.020.040.040.040.040.040.04
Exceptional Items 000000000
Profit Before Tax -0.05-0.09-0.29-0.42-0.06-0.22-0.07-0.100
Tax 000.010.010.010-0-0-0
Profit After Tax -0.05-0.09-0.30-0.43-0.06-0.22-0.07-0.090.01
PAT Margin (%) ---229.0%--256.0%-147.0%-17.2%-10.9%
Adjusted EPS (₹)-1.6-3.2-10.6-11.2-1.7-5.7-1.7-2.40.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.160.320.250.880.820.600.530.440.45
Share Capital 0.040.290.290.390.390.390.390.390.39
Reserves 0.120.03-0.040.500.430.210.150.060.06
Minority Interest000000000
Debt0.070.110.180.260.290.290.280.050.10
Long Term Debt000000000
Short Term Debt0.070.110.180.260.290.290.280.050.10
Trade Payables00.040.050.110.090.100.060.020.02
Others Liabilities 000.030.050.180.110.170.140.13
Total Liabilities 0.240.470.521.311.381.101.040.660.70

Fixed Assets

Gross Block0.180.180.370.370.370.370.370.370.37
Accumulated Depreciation000.020.060.100.130.170.210.25
Net Fixed Assets 0.180.180.350.310.270.240.200.160.13
CWIP 00.120000000
Investments 000000000
Inventories00.090.090.180.180.010.010.010.01
Trade Receivables000.03000000.10
Cash Equivalents 0.010.060.010.010.050.020.010.410.01
Others Assets 0.050.020.050.800.870.830.820.070.46
Total Assets 0.240.470.521.311.381.101.040.660.70

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.05-0.110.07-1.140.01-0.870.010.39-0.40
PBT -0.05-0.09-0.29-0.42-0.06-0.22-0.07-0.100
Adjustment 000.020.040.040.040.040.040.04
Changes in Working Capital -0-0.020.33-0.760.03-0.690.040.45-0.44
Tax Paid 000000000
Cash Flow From Investing Activity -0.05-0.12-0.19000000
Capex -0.05-0.12-0.19000000
Net Investments 000000000
Others 000000000
Cash Flow From Financing Activity 0.100.290.081.140.03-0.29-0.0200
Net Proceeds from Shares 0.080.2501.3500000
Net Proceeds from Borrowing 000000000
Interest Paid 000000000
Dividend Paid 000000000
Others 0.030.040.08-0.210.03-0.29-0.0200
Net Cash Flow 00.05-0.0500.04-1.16-0.010.39-0.40

Finance Ratio

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-27.59-77.28-804.02-97.83-7.53-31.12-11.64-18.632.01
ROCE (%)-19.45-27.62-66.2-53.57-5.23-21.88-7.88-14.520.95
Asset Turnover Ratio000.2600.020.120.3600.12
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A-40
Working Capital Days
Receivable Days007305000218
Inventory Days0025302,65823712055
Payable Days001830012515800

Transpact Enterprises Ltd Stock News

Transpact Enterprises Ltd FAQs

The current trading price of Transpact Enterprise on 20-Nov-2025 16:59 is ₹165.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Nov-2025 the market cap of Transpact Enterprise stood at ₹6.38.
The latest P/E ratio of Transpact Enterprise as of 19-Nov-2025 is 709.0.
The latest P/B ratio of Transpact Enterprise as of 19-Nov-2025 is 14.13.
The 52-week high of Transpact Enterprise is ₹299.4 and the 52-week low is ₹130.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transpact Enterprise is ₹0.08 ( Cr.) .

About Transpact Enterprises Ltd

Transpact Enterprises

Transpact Enterprises was incorporated as Transpact Enterprises Private Limited on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The certificate of incorporation was issued on May 12, 2013 by the Registrar of Companies, Mumbai at Maharashtra. Further the status of the Company was changed to public limited Company and the name of the company was changed to Transpact Enterprises Limited by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019, by the Registrar of Companies, Mumbai.

Business area of the company

Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Milestones:

  • May 2013: Incorporated as 'Transpact Enterprises Private Limited'
  • June 2015: Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator
  • December 2015: Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.
  • September 2016: Received ISO 9001:2015 certification for quality management system
  • October 2016: Received 13485:2016 certification for 'Medical devices'.
  • March 2018: Assessed and registered as compliance as per the requirements of Council Directive- Medical Devices Directive– 2007/47/EC by International Standards Registrations.
  • March 2019: Conversion of Private Company ' Transpact Enterprises Private Limited' to Public Company 'Transpact Enterprises Limited'.
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×